Microbiological and clinical outcome of gatifloxacin against NGU
| Urethritis | Pathogens | N | Microbiological outcomes (n=86) | Clinical outcomes (n=135) | ||||
| CT | MG | Urethral discharge | Micturation pain | Urethral discomfort | Urethral iching | |||
| CU | CT | 68 | 68/68 | – | 42/42 | 33/33 | 45/46 | 33/34 |
| CT+MG | 4 | 4/4 | 4/4 | 2/2 | 3/3 | 2/2 | 1/1 | |
| NCNGU | MG | 14 | – | 11/14 | 12/12 | 9/9 | 7/7 | 7/7 |
| Not detected | 48 | – | – | 33/33 | 21/21 | 33/33 | 23/23 | |
| Indeterminate for CT | 1 | – | – | 1/1 | – | 1/1 | 1/1 | |
| Total | 135 | 72/72 | 15/18 | 91/91 | 66/66 | 90/91 | 65/66 | |
CT, C trachomatis; CU, chlamydial urethritis; MG, M genitalium; NCNGU, non-chlamydial non-gonococcal urethritis; NGU, non-gonococcal urethritis.